Safety aspects of iodinated contrast media related to their physicochemical properties: A pharmacoepidemiology study in two Tuscany hospitals

European Journal of Clinical Pharmacology

Volumn 64, Issue 7, 2008, Pages 723-737

  Lapi, Francesco ^a   Cecchi, Enrica ^a,b   Pedone, Claudio ^c   Attanasio, Francesco ^d   Banchelli, Grazia ^a   Vannacci, Alfredo ^a   Di Pirro, Marina ^a   Moschini, Martina ^a   Berni, Valentina ^e   Matucci, Rosanna ^a   Cini, Elisabetta ^d   Scalia, Antonino ^e   Tendi, Enrico ^d   Mugelli, Alessandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b ASL 4 Hospital   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

^e ASL3 Hospital   (Italy)

Author keywords

Contrast media; Delayed ADRs; Immediate ADRs

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; CORTICOSTEROID DERIVATIVE; DIMERIC NONIONIC CONTRAST MEDIUM; IOBITRIDOL; IODINATED CONTRAST MEDIUM; IODIXANOL; IOMEPROL; IOPROMIDE; MONOMERIC NONIONIC CONTRAST MEDIUM; PARACETAMOL;

ABDOMINAL PAIN; ADULT; AGED; ARTHRALGIA; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DIARRHEA; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG MONITORING; DRUG SAFETY; FEMALE; FEVER; HEADACHE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; ITALY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYALGIA; NAUSEA AND VOMITING; PHARMACOEPIDEMIOLOGY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PRURITUS; QUESTIONNAIRE; RASH; URTICARIA;

ADOLESCENT; ADULT; AGED; ANGIOGRAPHY; CONTRAST MEDIA; FEMALE; HOSPITALS; HUMANS; IODINE; ITALY; MALE; MIDDLE AGED;

EID: 44449149680     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-008-0477-7     Document Type: Article

References (38)

1. Lasser EC (2004) Anaphylaxis. Novartis Found Symp 257:211-225
2. Persson PB (2005) Editorial: contrast medium-induced nephropathy. Nephrol Dial Transplant 20(Suppl 1):i1
3. Sangiorgi G (2003) Mezzi di contrasto e safety renale-cardiaca nel laboratorio di emodinamica. Emodinamica 89(9):990-992
4. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K (1990) Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175(3):621-628
5. Almen T (1994) The etiology of contrast medium reactions. Invest Radiol 29(1):S37-S45
6. Brockow K, Christiansen C, Kanny G, Clement O, Barbaud A, Bircher A, Dewachter P, Gueant JL, Rodriguez Gueant RM, Mouton-Faivre C, Ring J, Romano A, Sainte-Laudy J, Demoly P, Pichler WJ (2005) Management of hypersensitivity reactions to iodinated contrast media. Allergy 60(2):150-158
7. Meth MJ Maibach HI (2006) Current understanding of contrast media reactions and implications for clinical management. Drug Safety 29(2):133-141
8. Schild HH, Kuhl CK, Hubner-Steiner U, Bohm I, Speck U (2006) Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled trial. Radiology 240(1):56-64
9. Sutton AG, Finn P, Grech ED, Hall JA, Stewart MJ, Davies A, De Belder MA (2001) Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization. Am Heart J 141(4):677-683
10. Sutton AG, Finn P, Campbell PG, Price DJ, Hall JA, Stewart MJ, Davies A, Linker NJ, De Belder MA (2003) Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization. J Invasive Cardiol 15(3):133-138
11. Idee JM, Pines E, Prigent P, Corot C (2005) Allergy-like reactions to iodinated contrast agents. A critical analysis. Fundam Clin Pharmacol 19(3):263-281
12. Morcos SK (2003) Review article: Effects of radiographic contrast media on the lung. Br J Radiol 76(905):290-295
13. Webb JA, Stacul F, Thomsen HS, Morcos SK (2003) Late adverse reactions to intravascular iodinated contrast media. Eur Radiol 13(1):181-184
14. Thomsen HS (2006) European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media. Eur J Radiol 60(3):307-313
15. Mortelé KJ, Oliva MR, Ondategui S, Ros PR, Silverman SG (2005) Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital. AJR Am J Roentgenol 184(1):31-34
16. Morcos SK (2005) Review article: Acute serious and fatal reactions to contrast media: our current understanding. Br J Radiol 78(932):686-693
17. Dawson P (2006) Adverse reactions to intravascular contrast agents. BMJ 333(7570):663-664
18. Tramèr MR, von Elm E, Loubeyre P, Hauser C (2006) Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review. BMJ 333(7570):675-680
19. Olsson S (1998) The role of the WHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts. Drug Safety 19(1):1-10
20. Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, Carbonin P (1994) Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 10(4):405-411
21. PHS-HCFA International Classification Diseases, 9th revision (1980). Public Health Service-Health Care Financing Administration, Washington DC
22. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30(2):239-245
23. Morcos SK, Thomsen HS, Webb JA (2001) Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur Radiol 11(9):1720-1728
24. Mikkonen R, Kontkanen T, Kivisaari L (1995) Acute and late adverse reactions to low-osmolal contrast media. Acta Radiol 36(1):72-76
25. Hosoya T, Yamaguchi K, Akutsu T, Mitsuhashi Y, Kondo S, Sugai Y, Adachi M (2000) Delayed adverse reactions to iodinated contrast media and their risk factors. Radiat Med 18(1):39-45
26. Yoshikawa H (1992) Late adverse reactions to nonionic contrast media. Radiology 183(3):737-740
27. Esplugas E, Cequier A, Gomez-Hospital JA, Del Blanco BG, Jara F (2002) Comparative tolerability of contrast media used for coronary interventions. Drug Safety 25(15):1079-1098
28. Munechika H, Hiramatsu Y, Kudo S, Sugimura K, Hamada C, Yamaguchi K, Katayama H (2003) A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography. Eur Radiol 13(1):185-194
29. Lasser EC (2004) The radiocontrast molecule in anaphylaxis: a surprising antigen. Novartis Found Symp 257:211-224 discussion
30. Radhakrishnan S, Manoharan S, Fleet M (2005) Repeat survey of current practice regarding corticosteroid prophylaxis for patients at increased risk of adverse reaction to intravascular contrast agents. Clin Radiol 60(1):58-63
31. Drici MD, Clement N (2001) Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Safety 24(8):575-585
32. Lasser EC (1995) Gender risk for anaphylactoid reactions to contrast material. J Allergy Clin Immunol 96(6):1019-1020
33. Ansell G, Tweedie MC, West CR, Evans P, Couch L (1980) The current status of reactions to intravenous contrast media. Invest Radiol 15(6):S32-S39
34. Leone R, Conforti A, Venegoni M, Motola D, Moretti U, Meneghelli I, Cocci A, Sangiorgi CG, Scotto S, Montanaro N, Velo G (2005) Drug-induced anaphylaxis: case/non-case study based on an italian pharmacovigilance database. Drug Safety 28(6):547-556
35. Benahmed S, Picot MC, Dumas F, Demoly P (2005) Accuracy of a pharmacovigilance algorithm in diagnosing drug hypersensitivity reactions. Arch Intern Med 165(13):1500-1505
36. Macedo AF, Marques FB, Ribeiro CF (2006) Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs? Drug Safety 29(8):697-702
37. Crowne DP, Marlowe D (1960) A new scale of social desirability independent of psychopathology. J Consult Psychol 24:349-354
38. Marlowe D, Crowne DP (1961) Social desirability and response to perceived situational demands. J Consult Psychol 25:109-115